checkAd
    Startseite > Aktien > NightHawk Biosciences > Nachrichten
    NightHawk Biosciences Aktie
    0,1743
     
    USD
    -19,01 %
    -0,0409 USD
    Letzter Kurs 16:37:10 NYSE Arca
    0,1628
     
    USD
    100 STK
    Geldkurs 16:37:10
    0,1800
     
    USD
    100 STK
    Briefkurs 16:37:10
    ISIN: US42237K4094 · WKN: A2QJR8 · SYM: SCPX · USA

    Neueste Nachrichten

    Scorpius Holdings Provides 2023 Year-End Business Update; Reports 570% Sequential Increase in Revenue for the Fourth Quarter of 2023
    29.04.24 · globenewswire · NightHawk Biosciences
    Scorpius Holdings Announces Receipt of Filing Delinquency Notification
    22.04.24 · globenewswire · NightHawk Biosciences
    Scorpius Holdings Awarded Contract in Excess of $1 Million with NIH-Funded Researcher at a Major University
    19.03.24 · globenewswire · NightHawk Biosciences
    Scorpius Holdings Accepted as a Member of the US Government’s BioMaP-Consortium
    14.03.24 · globenewswire · NightHawk Biosciences
    Scorpius Holdings, Inc. Announces Closing of Public Offering
    12.03.24 · globenewswire · NightHawk Biosciences
    Scorpius Holdings, Inc. Announces Pricing of Public Offering
    08.03.24 · globenewswire · NightHawk Biosciences
    Scorpius Holdings, Inc. Announces Proposed Public Offering of Common Stock
    07.03.24 · globenewswire · NightHawk Biosciences
    Scorpius Holdings Estimates Greater than 375% Sequential Increase in Revenue for the Fourth Quarter of 2023 Compared to the Third Quarter of 2023
    07.03.24 · globenewswire · NightHawk Biosciences
    NightHawk Biosciences Completes Name Change to Scorpius Holdings; Trading to Commence Under “SCPX” Effective at the Market Open Today
    06.02.24 · globenewswire · NightHawk Biosciences
    NightHawk’s Scorpius BioManufacturing Subsidiary Announces the Promotion of Joe Payne to President and Chief Operating Officer
    01.02.24 · globenewswire · NightHawk Biosciences
    NightHawk Receives Proceeds of $3.25 Million in Connection with Sale of Non-Core Intellectual Property and Issuance of a Low Interest Bearing Note
    30.01.24 · globenewswire · NightHawk Biosciences
    NightHawk’s Scorpius BioManufacturing Subsidiary Awarded Multimillion- Dollar Contract with a Publicly Traded Biotech Company to Support its Phase 2 Clinical Program
    25.01.24 · globenewswire · NightHawk Biosciences